'4 Weeks, ₩130,000' K-Mounjaro Finally Launches; What About Hanmi Pharm Shares?
Predicted impact: Medium
Obesity drug launch was already reported in recent days; this is a follow-up with no new size data.
Comments
No comments yet. Start the conversation.
Comments are people's own views. Nothing here is financial advice.